{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T15:43:27Z","timestamp":1758815007565},"reference-count":25,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2008,3,17]],"date-time":"2008-03-17T00:00:00Z","timestamp":1205712000000},"content-version":"vor","delay-in-days":9786,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Endocrinology"],"published-print":{"date-parts":[[1981,6]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p>The outcome of a standardized carbimazole (CMI) regimen was evaluated in fifty\u2010four patients with Graves' disease. Triiodothyronine (T3) and thyroxine (T4) serum values were determined before and throughout the first 6\u20138 months of therapy. Before therapy, decreasing T4\/T3 ratios were found with increasing T3 levels, reflecting a relative increase in T3 production compared with T4 in thyrotoxicosis. High pretreatment T3 values were comparatively common among patients in whom a fixed CMI dosage had an insufficient effect. T4 levels were less informative in this respect. Serum levels of methimazole (MMI), the active metabolite of CMI, were dose\u2010dependent. A 50% reduction in dosage resulted in a similar decrease in the serum values. For a given dose, the MMI levels differed considerably among individuals. The variation was not related to thyroid hormone values. It appears that the response to the anti\u2010thyroid drug is primarily dependent upon the severity of the disease, which is clearly reflected in serum T3 levels, rather than individual differences in drug handling. A routine CMI regimen for the treatment of thyrotoxicosis is suggested.<\/jats:p>","DOI":"10.1111\/j.1365-2265.1981.tb02965.x","type":"journal-article","created":{"date-parts":[[2008,3,17]],"date-time":"2008-03-17T13:07:57Z","timestamp":1205759277000},"page":"555-562","source":"Crossref","is-referenced-by-count":20,"title":["STUDIES OF THYROID HORMONE AND METHIMAZOLE LEVELS IN PATIENTS WITH GRAVES' DISEASE ON A STANDARDIZED ANTI\u2010THYROID DRUG REGIMEN"],"prefix":"10.1111","volume":"14","author":[{"given":"P. A.","family":"DAHLBERG","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. A.","family":"KARLSSON","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"LINDSTROM","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"WIDE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,3,17]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0300-595X(78)80044-9"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(76)92774-4"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.0954-6820.1980.tb09741.x"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-34-5-891"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-4347(00)81651-5"},{"key":"e_1_2_1_7_1","first-page":"893","article-title":"The management of thyrotoxicosis","volume":"11","author":"Havard C.W.H.","year":"1974","journal-title":"British Journal of Hospital Medicine"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0028-1106542"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(71)92102-7"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1976.tb03872.x"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI108734"},{"key":"e_1_2_1_12_1","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S0025-7125(16)31957-5","article-title":"Tests of thyroid function","volume":"59","author":"Larsen P.R.","year":"1975","journal-title":"Medical Clinics of North America"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1210\/endo-102-3-757"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-34-5-847"},{"key":"e_1_2_1_15_1","first-page":"305","article-title":"Antithyroid drugs","volume":"3","author":"Marchant B.","year":"1978","journal-title":"Pharmacology and Therapeutics (b)"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(75)92006-1"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00625803"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1979.tb02122.x"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.242.3.275"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(74)90628-7"},{"key":"e_1_2_1_21_1","first-page":"137","article-title":"Thyroidal and peripheral production of thyroid hormones: review of recent findings and their clinical implications. Annals of Internal Medicine, 87, 760\u2013768. Skellern, G.G., Knight, B.I., Low, C.K.L., Alexander, W.D., McLarty, D.G. & Kalk, W.J. (1980) The pharmacokinetics of methimazole after oral administration of carbimazole and methimazole, in hyperthyroid patients","volume":"9","author":"Schimmel M.","year":"1977","journal-title":"British Journal of Clinical Pharmacology"},{"key":"e_1_2_1_22_1","first-page":"814","volume-title":"The Thyroid","author":"Solomon D.H.","year":"1978"},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-37-3-485"},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-41-1-191"},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.5165.1"},{"key":"e_1_2_1_26_1","first-page":"207","article-title":"Radioimmunoassay employing immunosorbents","volume":"142","author":"Wide L.","year":"1969","journal-title":"Acta Endocrinologica"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2265.1981.tb02965.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2265.1981.tb02965.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,11]],"date-time":"2023-11-11T09:41:06Z","timestamp":1699695666000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2265.1981.tb02965.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1981,6]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1981,6]]}},"alternative-id":["10.1111\/j.1365-2265.1981.tb02965.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2265.1981.tb02965.x","archive":["Portico"],"relation":{},"ISSN":["0300-0664","1365-2265"],"issn-type":[{"value":"0300-0664","type":"print"},{"value":"1365-2265","type":"electronic"}],"subject":[],"published":{"date-parts":[[1981,6]]}}}